Health
Pfizer seeking FDA approval for RSV vaccine
Pfizer is working on an RSV vaccine for newborns and now says it has enough data to seek approval from the FDA.
Top Stories
Trending
- Political pressure from Somali community hampered Minnesota fraud probes, whistleblower says
- Trump repeats claim NATO does not support US when needed after Rutte meeting
- Hegseth says U.S. has right to conduct Midnight Hammer-type attack over Iran’s enriched uranium
- Former SOCOM worker arrested for allegedly leaking classified information to media: Suspect named
- Ceasefire agreement on uncertain ground due to disputes over Lebannon bombing and Hormuz